Crohn’s Disease
About The Study
As you know, Crohn’s disease is a chronic inflammatory bowel disease that causes inflammation or ulceration in the digestive tract.
The purpose of this clinical research study is to evaluate whether treatment with the investigational medication is effective by looking at the endoscopic response and patient outcomes compared to a placebo or an active comparator. “Investigational” means that the medication being tested has not been approved for use by doctors in their everyday practice and that its use is being allowed for research only. Individuals will be evaluated to determine their eligibility to participate in this study
Eligibility Criteria
- Adults ages 18 to 80 who have been diagnosed with moderate to severe Crohn’s disease for at least three months
- Those who have had an inadequate response to, loss of response to, or intolerance to at least one approved conventional or biologic treatment or therapy for Crohn’s disease
- Those who are willing and able to complete the scheduled study assessments, including endoscopy and a daily diary entry
Contact Us for Unparalleled Clinical Research Solutions
Discover how our expertise and dedication can accelerate your research success